- Country: Guatemala
- Summary: Purchase of Montelukast 5Mg Tablet, Metformin 500Mg Tablet, Neomycin D Sulfate Clostebol Cream, Cefadroxil Suspension and Zinc Sulfate 20Mg Tablet; for the Medical Accessibility Program...
- GTT Ref No: 100053374
- Deadline: 17 Apr 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 22768882
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Purchase Of Montelukast 5mg Tablet, Metformin 500mg Tablet, Neomycin D Sulfate Clostebol Cream, Cefadroxil Suspension And Zinc Sulfate 20mg Tablet; For the Medication Accessibility Program -proam-.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPurchase of Montelukast 5Mg Tablet, Metformin 500Mg Tablet, Neomycin D Sulfate Clostebol Cream, Cefadroxil Suspension and Zinc Sulfate 20Mg Tablet; for the Medical Accessibility Program... - Guatemala Tender
The MINISTRY OF PUBLIC HEALTH, a Government sector organization in Guatemala, has announced a new tender for Purchase of Montelukast 5Mg Tablet, Metformin 500Mg Tablet, Neomycin D Sulfate Clostebol Cream, Cefadroxil Suspension and Zinc Sulfate 20Mg Tablet; for the Medical Accessibility Program.... This tender is published on GuatemalaTenders under GTT Ref No: 100053374 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-04-17.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
